CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15 | -48.3% | 21,786 | -11.1% | 0.00% | – |
| Q2 2023 | $29 | -99.3% | 24,497 | +624.1% | 0.00% | – |
| Q3 2022 | $4,000 | -33.3% | 3,383 | -48.7% | 0.00% | – |
| Q2 2022 | $6,000 | -83.3% | 6,595 | -67.2% | 0.00% | – |
| Q1 2022 | $36,000 | -91.5% | 20,112 | -92.7% | 0.00% | – |
| Q4 2021 | $424,000 | +351.1% | 275,662 | +494.0% | 0.00% | – |
| Q3 2021 | $94,000 | -48.6% | 46,406 | -11.7% | 0.00% | – |
| Q2 2021 | $183,000 | +976.5% | 52,575 | +462.6% | 0.00% | – |
| Q1 2021 | $17,000 | – | 9,345 | +84854.5% | 0.00% | – |
| Q4 2019 | $0 | – | 11 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Key Bridge Compliance, LLC | 154,130 | $105,487 | 0.03% |
| CHELSEA COUNSEL CO | 81,300 | $55,642 | 0.03% |
| Inspire Advisors, LLC | 186,410 | $127,579 | 0.02% |
| Horst & Graben Wealth Management LLC | 75,722 | $51,824 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 198,492 | $136 | 0.01% |
| Arkadios Wealth Advisors | 100,000 | $68,440 | 0.01% |
| Miller Investment Management, LP | 50,000 | $34,220 | 0.01% |
| XTX Topco Ltd | 29,077 | $19,900 | 0.00% |
| Measured Wealth Private Client Group, LLC | 10,000 | $6,844 | 0.00% |
| Pasadena Private Wealth, LLC | 10,965 | $7,504 | 0.00% |